As on 13-Aug-2024 IST
₹1,556.95
₹1,569.35
₹1,594.00
₹1,542.20
1,18,567
₹954.00 - 1,655.00
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Caplin Point Lab
| 15.93 | 3.49 | 22.69 | 52.27 | 22.67 | 30.37 | 36.77 |
BSE Healthcare
| 30.05 | 6.86 | 18.26 | 46.79 | 16.31 | 26.45 | 12.81 |
BSE Small Cap
| 24.81 | -1.39 | 17.32 | 50.92 | 26.42 | 33.21 | 18.27 |
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
---|---|---|---|---|---|---|---|
Caplin Point Lab
| 90.12 | -16.88 | 69.91 | 71.89 | -21.39 | -39.75 | 84.02 |
BSE Small Cap
| 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 | 59.64 |
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
The total asset value of Caplin Point Laboratories Ltd stood at ₹ 2,697 Cr as on 30-Jun-24
The share price of Caplin Point Laboratories Ltd is ₹1,572.15 (NSE) and ₹1,571.40 (BSE) as of 13-Aug-2024 IST. Caplin Point Laboratories Ltd has given a return of 22.67% in the last 3 years.
Caplin Point Laboratories Ltd has a market capitalisation of ₹ 11,944 Cr as on 13-Aug-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Caplin Point Laboratories Ltd is 4.89 times as on 13-Aug-2024, a 20% discount to its peers’ median range of 6.09 times.
The P/E ratio of Caplin Point Laboratories Ltd is 25.01 times as on 13-Aug-2024, a 41% discount to its peers’ median range of 42.30 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Caplin Point Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Caplin Point Laboratories Ltd.
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. It provides liquid and lyophilized vials, pre-filled syringes, 3-pc ophthalmic droppers, pre-mix bags, dry and liquid syrups-bottles, tables, soft gels, capsules, suppositories, liquid and emulsion injectables in ampoules and vials, topicals, and sachets. The company was incorporated in 1990 and is headquartered in Chennai, India.
The prominent promoters of Caplin Point Laboratories Ltd. are
Name of promoters | Holding percentage |
---|---|
P VIJAYALAKSHMI |
24.71%
|
PAARTHIPAN C C |
18.64%
|
ASHOK GORKEY PARTHEEBAN |
11.91%
|
PARTHEEBAN VIVEK SIDDARTH |
11.84%
|
MAY INDIA PROPERTY PRIVATE LIMITED |
2.79%
|
The chairman of the company is C C Paarthipan, and the managing director is Sridhar Ganesan.
There is no promoter pledging in Caplin Point Laboratories Ltd.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
10,506
|
|
7,981
|
|
6,869
|
|
3,620
|
Caplin Point Laboratories Ltd. | Ratios |
---|---|
Return on equity(%)
|
21.76
|
Operating margin(%)
|
29.51
|
Net Margin(%)
|
26.32
|
Dividend yield(%)
|
0.16
|
Yes, TTM profit after tax of Caplin Point Laboratories Ltd was ₹478 Cr.
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. It provides liquid and lyophilized vials,... pre-filled syringes, 3-pc ophthalmic droppers, pre-mix bags, dry and liquid syrups-bottles, tables, soft gels, capsules, suppositories, liquid and emulsion injectables in ampoules and vials, topicals, and sachets. The company was incorporated in 1990 and is headquartered in Chennai, India. Read more